NIOSHTIC-2 Publications Search
Release of human growth hormone, follicle stimulating hormone, and luteinizing hormone in response to L-dihydroxy-phenylalanine (L-dopa) in normal man.
Perlow-MJ; Sassin-JF; Boyar-R; Hellman-L; Weitzman-ED
Dis Nerv Syst 1972 Dec; 33(12):804-810
Oral administration of 0.5 milligram L-Dopa (59927) to normal young men induced release of human-growth-hormone (9002726) 40-90 minutes after treatment. There were no significant differences in the levels of plasma luteinizing-hormone (9002679) and follicle- stimulating hormone between treated and control subjects. The single, low dose of L-Dopa induced infrequent nausea, vomiting, mild headache, "feeling cold", and orthostatic hypotension.
NIOSH-Publication; NIOSH-Grant; Grants-other; Endocrine-function; Pituitary-functions; Digestive-disorders; Cardiovascular-system-disorders; Toxicology
Division of Neurology Montefiore Hosp and Med Center Division of Neurology Bronx, N Y 10467
59-92-7; 9002-72-6; 9002-67-9
Issue of Publication
Other Occupational Concerns; Grants-other
Diseases of the Nervous System
Montefiore Hospital and Medical Center, New York, New York
Page last reviewed: April 12, 2019
Content source: National Institute for Occupational Safety and Health Education and Information Division